- Filed
- May 14, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 14, 2025 | 1.79M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $20.6M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $23.08M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $9.06M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $9.18M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $88.75M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $90.97M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 1.85M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $1.33M |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$1.49M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $81.84M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $83.71M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.56 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.56 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $1.31M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$1.03M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$1.47M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $662K |
| Revenue | Q1 2025 · Mar 31, 2024 | $541K |